Author

Qiuyan Yu

Observed name: Yu, Qiuyan

Institutions: Laboratory of Data Discovery for Health, University of Hong Kong

Observed institutions: Laboratory of Data Discovery for Health, University of Hong Kong

ORCID: 0000-0002-5385-7185

Observed ORCID: 0000-0002-5385-7185

OpenAlex ID: A5121994718

Real-world evidence on prescribing patterns and lipid-lowering effectiveness of monoclonal antibody PCSK9 inhibitors from Hong Kong

2026 · Bingbing Zhu, Yuexi Liao, et al. · European Journal of Preventive Cardiology · 2

PCSK9 inhibitors usage in South China: A Multi-Center Real-World Study

2026 · Qiuyan Yu, Tiantian Ma, et al. · Drugs - Real World Outcomes

Risk of Cancer Comparing Warfarin and Direct Oral Anticoagulants: Population-Based Cohort Studies in England and Hong Kong

2026 · Zixuan Wang, Qiuyan Yu, et al. · Drug Safety

Works count: 4

Citation count: 2

H-index: 1

I10-index: